Mast cell sarcoma with KIT p.D816V mutation and concurrent systemic mastocytosis

Nicholas Collins1, Nicholas Willard1, Zenggang Pan2

  • 1Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, USA.

PubMed
Summary

Mast cell sarcoma (MCS) is a rare cancer. This report details a unique case of MCS with concurrent systemic mastocytosis (SM), both featuring the KIT p.D816V mutation, suggesting a potential progression pathway.